Spasers seek and destroy metastasized cancer cells
Researchers have developed a method of finding and destroying metastasized cancer cells in the blood stream without damaging healthy cells.
The nanolaser – dubbed spaser - can be used as an optical probe. When released into the body (possibly through an injection or drinking a solution), it can find circulating tumour cells (CTCs), adhere to them and destroy these cells by breaking them apart to prevent cancer metastases. The spaser is claimed to work by absorbing laser light, which causes it to heat up, causing shock waves in the cell and destroying the cell membrane. The findings are published in Nature Communications.
The spaser - surface plasmon amplification by stimulated emission of radiation - effect is caused by a 20nm nanoparticle with folic acid attached to its surface that allows selective molecular targeting of cancer cells.
According to the research team – from Georgia State University, the University of Arkansas for Medical Sciences, the University of Arkansas at Little Rock and the Siberian Branch of the Russian Academy of Science - the folate receptor is commonly overexpressed on the surface of most human cancer cells and is weakly expressed in normal cells.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
National Gas receives funding to develop Gravitricity underground hydrogen storage system
One single rock salt mine - Winsford - has 23 <i>MILLION </i>cubic metres of void and even allowing for 10% of that void set aside for hazardous waste...